Hepatocellular carcinoma in Txnip-deficient mice

S S Sheth1, J S Bodnar, A Ghazalpour

  • 1Department of Human Genetics, University of California Los Angeles, 47-123 CHS, David Geffen School of Medicine at UCLA, 90095-1679, USA.

Oncogene
|April 12, 2006
PubMed
Summary

Thioredoxin interacting protein (Txnip) deficiency significantly increases hepatocellular carcinoma (HCC) risk in mice. Txnip acts as a tumor suppressor, and its absence initiates HCC development, revealing new insights into liver cancer.

Related Concept Videos